Cardioverter–defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction

被引:0
作者
Clemens Jilek
Thorsten Lewalter
Matthias Pauschinger
Wolfgang von Scheidt
Lutz Frankenstein
Otmar Pfister
Rainer Hambrecht
Oliver Bruder
Johannes Brachmann
Andreas Hartmann
Ruth Strasser
Matthias Hochadel
Jochen Senges
机构
[1] Peter Osypka Herzzentrum München,Klinik für Kardiologie
[2] Internistisches Klinikum München Süd,Klinik für Innere Medizin und Kardiologie
[3] Klinik für Kardiologie,undefined
[4] Klinikum Nürnberg,undefined
[5] I. Medizinische Klinik,undefined
[6] Klinikum Augsburg,undefined
[7] Klinik für Innere Medizin III: Kardiologie,undefined
[8] Angiologie und Pneumologie,undefined
[9] Uniklinikum,undefined
[10] Universitätsspital Basel,undefined
[11] Klinik für Kardiologie und Angiologie,undefined
[12] Klinikum links der Weser,undefined
[13] Klinik für Kardiologie und Angiologie,undefined
[14] Elisabeth-Krankenhaus Essen,undefined
[15] Klinik für Kardiologie,undefined
[16] Angiologie und Pneumologie,undefined
[17] Regiomed Kliniken Coburg,undefined
[18] Klinik für Kardiologie,undefined
[19] Angiologie und Internistische Intensivmedizin,undefined
[20] Uniklinikum Dresden,undefined
[21] Stiftung Institut für Herzinfarktforschung Ludwigshafen,undefined
来源
Clinical Research in Cardiology | 2020年 / 109卷
关键词
Non-ischemic cardiomyopathy; Sudden cardiac death; Primary prevention; Implantable cardioverter–defibrillator;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:115 / 123
页数:8
相关论文
共 236 条
[1]  
Priori SG(2015)2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Eur Heart J 36 2793-2867
[2]  
Blomström-Lundqvist C(2005)Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 225-237
[3]  
Mazzanti A(2004)Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2151-2158
[4]  
Blom N(2017)Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice Journal of Cardiovascular Electrophysiology 28 666-673
[5]  
Borggrefe M(2016)Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure N Engl J Med 375 1221-1230
[6]  
Camm J(2017)Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials Eur Heart J. 38 1738-1746
[7]  
Elliott PM(2017)Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials Clin Res Cardiol 106 501-513
[8]  
Fitzsimons D(2009)Cardiac-resynchronization therapy of the prevention of heart-failure events N Engl J Med 361 1329-1338
[9]  
Hatala R(2005)The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 1539-1549
[10]  
Hindricks G(2010)Cardiacresynchronization therapy for mild-to-moderate heart failure N Engl J Med. 363 2385-2395